New York State Contract Reporter #2134582

Hepatitis C Point-of-Care Diagnostic Instruments for Opioid Treatment Programs

The New York State Department of Health AIDS Institute is providing targeted funding to support rapid hepatitis C diagnosis in opioid treatment programs across New York State. - Government Buyer: - New York State Department of Health, AIDS Institute - Office of Administration and Contract Management - Award Recipients: - Greenwich House - StartCare Inc. - Helio Health - Products/Services Requested: - Hepatitis C point-of-care diagnostic testing instruments - Quantity: 3 units (one per contract) - Capable of providing diagnosis within one hour - Associated supplies required for instrument operation - Notable Requirements: - Instruments must enable rapid identification and treatment of hepatitis C to reduce patient loss between testing and diagnosis - Procurement is sole/single source due to unique qualifications of the selected entities - Supports New York State's goal to eliminate hepatitis C by 2030 - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or diagnostic instrument brands are named in the procurement notice - Place of Performance: - State-wide implementation across New York - Administrative office: Corning Tower, Room 359, Empire State Plaza, Albany, NY

Description

The New York State Department of Health AIDS Institute intends to add one-time funding of $50,000 each to three contracts in the Hepatitis C Nurse Care Coordination in Opioid Treatment Programs initiative. This funding will enable each participating site to purchase a hepatitis C point-of-care diagnostic testing instrument and associated supplies, providing diagnosis within one hour of testing. The initiative aims to rapidly identify and begin treatment for clients positive for hepatitis C, reducing patient loss between testing and diagnosis. New York State is committed to eliminating hepatitis C by 2030, and this increased testing and treatment capacity supports that goal. Due to the specific circumstances and unique qualifications of the selected entities, a competitive procurement was not feasible.

View original listing